Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Adult Antidepressant Suicidality Analysis Will Take At Least A Year

Executive Summary

FDA expects its assessment of data on suicidal thinking and behavior in adults on antidepressants will take at least a year to complete

You may also be interested in...



FDA Stance On Antidepressant Warnings Unchanged By NIMH Suicide Findings

A National Institute of Mental Health-funded study showing no increased risk of suicide with newer antidepressants does not change FDA's stance on the need for warnings about suicidality for the drug class

FDA Stance On Antidepressant Warnings Unchanged By NIMH Suicide Findings

A National Institute of Mental Health-funded study showing no increased risk of suicide with newer antidepressants does not change FDA's stance on the need for warnings about suicidality for the drug class

J&J To Promote Dapoxetine With “Responsible” DTC Campaign

Johnson & Johnson plans to support the launch of the premature ejaculation therapy dapoxetine with a "responsible" direct-to-consumer advertising campaign, J&J Consumer Pharmaceuticals & Nutritionals Group Chairman Rosemary Crane said May 26 during the company's R&D day in New York

Related Content

Topics

UsernamePublicRestriction

Register

OM013214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel